We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4208:TSEUBE Corporation Analysis

Data as of 2026-03-17 - not real-time

¥2,526.50

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: UBE is trading at ¥2,526.5, below the 20‑day (¥2,717.8) and 50‑day (¥2,704.4) SMAs but still above the 200‑day SMA (¥2,429.9), indicating a longer‑term bullish bias yet short‑term weakness. The RSI sits at 37.8, edging toward oversold territory, while the MACD line remains well under its signal (‑51.3 vs ‑22.1) and the histogram is negative, signaling bearish momentum in the near term.
Fundamental picture: The company delivers modest revenue growth (2.5%) with thin margins (gross 22.7%, operating 5.1%). Valuation appears attractive on a value basis – price‑to‑book 0.58 and price‑to‑sales 0.53 – and the DCF suggests an 8% upside to ¥3,740. However, the trailing PE is lofty at 42.6, offset by a forward PE of 7.4 thanks to a sharp EPS lift. A high dividend yield of 4.36% is offset by an unsustainable payout ratio of 186%, and the balance sheet is strained with a debt‑to‑equity of 80 and negative free cash flow.
Risk & outlook: Volatility is elevated (≈38% 30‑day) but beta is low (≈0.46), tempering market‑wide risk. Leverage and cash‑flow deficits pose the primary downside, while the cheap book value, strong dividend yield (if normalized) and forward earnings growth provide upside catalysts toward the fair‑value target.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price below short‑term SMAs
  • bearish MACD and negative histogram
  • oversold RSI suggesting limited downside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • forward PE of 7.4 indicating earnings acceleration
  • DCF upside of ~8% and cheap book value
  • increasing volume supporting liquidity

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • high debt‑to‑equity and negative free cash flow
  • unsustainable dividend payout ratio
  • diversified product mix across chemicals and machinery

Key Metrics & Analysis

Financial Health

Revenue Growth2.50%
Profit Margin7.70%
P/E Ratio42.6
ROE8.76%
ROA1.64%
Debt/Equity80.05
P/B Ratio0.6
Op. Cash Flow¥62.9B
Free Cash Flow¥-33875499008

Technical Analysis

TrendBullish
RSI37.8
Support¥2,474.00
Resistance¥2,888.50
MA 20¥2,717.75
MA 50¥2,704.44
MA 200¥2,429.93
MACDBearish
VolumeIncreasing
Fear & Greed Index77.89

Valuation

Fair Value¥3,740.20
Target Price¥2,740.00
Upside/Downside8.45%
GradeUndervalued
TypeBlend
Dividend Yield4.36%

Risk Assessment

Beta0.46
Volatility37.77%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.